Identification of PANoptosis-Based Prognostic Signature for Predicting Efficacy of Immunotherapy and Chemotherapy in Hepatocellular Carcinoma

<div>HCC clustering based on the differentially expressed PANoptosis-related genes. (a) Identification of three HCC clusters by consensus clustering analyses. (b) A good distinction between two clusters is shown in PCA. (c) KM analysis of the two clusters. (d) Heatmaps showed the relationship between the two clusters and DEGs’ expression. (e) Boxplot of the expression of DEGs between the clusters. (f) GSEA for the KEGG pathways activated in clusters 3 and 2.</div>

Genetics Research

fig2

Figure 2

Figure 2: Identification of PANoptosis-Based Prognostic Signature for Predicting Efficacy of Immunotherapy and Chemotherapy in Hepatocellular Carcinoma 

Figure 2 | Identification of PANoptosis-Based Prognostic Signature for Predicting Efficacy of Immunotherapy and Chemotherapy in Hepatocellular Carcinoma 